Neudle.com: dopaminergic desensitization

Differential
(Click to cross reference)

acetylcholine

acrochordon

acromegaly

activities of daily living

Addison's disease

advances in neurology

adverse drug reaction

alcohol, neurologic complications with

alcoholism

alopecia

alpha methyldopa hydrazine

alpha methyltyrosine

alpha-synuclein

altered states of consciousness, driving with

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, etiology of

anasarca

anemia, iron deficiency

angiography, cerebral

ankle edema

anticholinergic drugs

anticholinergic drugs, side effects of

anticonvulsants

anxiety

aortic valve, lesion of

aphasia

aphasia, rehabilitation

apomorphine

arrhythmia, cardiac

arterial dissection, aorta, cerebral symptoms with

arteriopathy

ataxia, truncal

attention deficit disorder with hyperactivity

atypical

automobile accidents

autonomic dysfunction

basal ganglia, lesion of

behavioral disorder

benzodiazepine

beta adrenergic blocker

bitemporal visual field defect

brain implant, polymeric

brain transplantation

bromocriptine

bromocriptine, slow release

carpal tunnel syndrome

CAT scan, emission, abnormal

catecholamine

catechol-o-methyltransferase inhibitor

cerebellar pontine angle

cerebellar pontine angle tumor

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, leak

cerebrovascular accident

cerebrovascular accident, women

chest x-ray, abnormal

Chiari Frommel syndrome

chromophobe adenoma, treatment of

chromosomal abnormality

cirrhosis

cisternogram, radionuclide

congestive heart failure

conjunctival injection

constipation

controversies in neurology

coronary artery disease

cough

cranial nerve palsies

degenerative diseases of CNS

dexamethasone suppression test

disability rating scale, neurological

disability, neurological

diurnal variation

domperidone

dopa responsive dystonia

dopamine

dopamine agonist

dopamine agonist withdrawal syndrome

dopamine antagonist

dopamine antagonist, peripheral

dopamine receptor

dopamine receptor, D2

dopaminergic desensitization

dopaminergic dysfunction

dopaminergic neurons

doppler, transcranial

downward gaze, paralysis of

driving

drug induced neurologic disorders

dystonia musculorum deformens

dystonia, face

dystonia, focal

echocardiogram

echocardiogram, transthoracic

edema, pedal

efficacy

electroconvulsive therapy

emergencies, neurologic

epidemiology of neurology

eye movement, disorders of

fine motor function, impaired

flushing

follicle stimulating hormone

gamma amino butyric acid

gastrointestinal bleeding

gaze palsy, horizontal

gaze palsy, vertical

gene

gene mutation

genetic neurologic disorders

Gilles de la Tourette syndrome

glabellar sign

glomus jugulare tumor

goiter

growth hormone

growth hormone deficiency

hair, loss

hallucination

hallucination, auditory

haloperidol

handwriting

headache

headache, drug induced

headache, treatment of

hearing loss

hemidystonia

hepatic encephalopathy

hepatic encephalopathy, treatment of

heralding manifestation

hypotension, systemic

hypothalamus, damage to

hypothermia

hypothyroidism

iatrogenic neurologic disorders

internuclear ophthalmoplegia

intracerebral hemorrhage

L-dopa, controlled release

L-dopa, drug interactions with and side effects of

L-dopa, potentiators of

lergotrile

Lesch-Nyhan syndrome

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

locus ceruleus, lesion of

medication withdrawal

microsurgery, transsphenoidal

migraine

migraine, menses

migraine, treatment of

misdiagnosis

mitochondrial disease

mitral valve lesion

mitral valve regurgitation

molecular genetics

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, extrapyramidal-treatment of

movement disorder, treatment of

MPTP

MRI

MRI, abnormal

MRI, contrast enhanced

neoplasm, hormone producing

neoplasm, hormone producing, ectopic

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-treatment of

neoplasm, pituitary

neoplasm, pituitary, incidental

neoplasm, pituitary, treatment of

neoplasm, primary of CNS-metastasizing to subarachnoid space

neoplasm, primary of CNS-treatment of

neurochemistry

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications of, surgery

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neurologic testing

neuronal degeneration

neurons

neuropathology

neuropathology, brain

neuropathy

neuroprotective agents

neurotoxic

neurotransmitter

nigrostriatal pathway

norepinephrine

obsessive-compulsive disorder

optic chiasm, herniation

oral contraceptives

oral contraceptives, neurologic complications with

orthostatic hypotension

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, driving with

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

parsidol

pathologic gambling

pathology

patient information and support

PHNO, enteral infusion, continuous

pituitary, adenoma, giant

pituitary, enlargement

pituitary, hormones of

pituitary, lesion of

pituitary, microadenoma

polyps, gastrointestinal tract

polysomnogram

postpartum

postpartum cerebral angiopathy

practice guidelines

pramipexole

pramipexole, extended release

pregabalin

pregnancy, neurologic complications in

PRKN gene

procyclidine

prognosis

progressive supranuclear palsy

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

radioimmunoassay

radiotracer imaging

raphe nuclei

reserpine and reserpine like drugs

respiratory failure

restless arms syndrome

restless genital syndrome

restless leg syndrome

retroperitoneal fibrosis

risk-benefit assessment

ritalin

ropinirole

ropinirole, prolonged release

rotigotine

safety

seizure

sella turcica, enlargement of

sensorineural hearing loss

single photon emission computed tomography

skin, lesions in neurologic disorders

skull x-ray

skull x-ray, abnormal

sleep

sleep apnea

sleep pathology and physiology

smell

Smell Identification Test

somatostatin analogue

stem cell transplantation

stereotyped behavior

stereotyped behavior, drug induced

stereotypy

stimulation, deep brain

striatum, lesion of

subclavian steal syndrome, causes of

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

tardive dyskinesia, treatment of

testicular atrophy

testosterone, serum

testosterone, serum, low

transdermal medication

trauma

treatment of neurologic disorder

tremor

tremor, resting

tremor, thalamic stimulation for suppression of

tricuspid valve, lesion of

tricyclic antidepressant

trismus

twins

undiagnosed

Unified Parkinson Rating Scale

visual acuity, decreased

Showing articles 200 to 236 of 236 << Previous

Lisuride in Parkinsonism
Neurol 31:371-376, Gopinathan,G.,et al, 1981

Treatment of Advanced Parkinson Disease With Pergolide
Neurol 31:675-682, Lieberman,A.,et al, 1981

Akinetic Mutism from Hypothalamic Damage:Successful Treatment with Dopamine Agonists
Neurol 31:1435-1439, Ross,E.D.,et al, 1981

Alcohol Increases Bromocriptine's Side Effects
NEJM 302:806, Ayres,J.,et al, 1980

Alzheimer's Disease
Editorial, BMJ 281:1374-13751980., , 1980

Increased Hair Loss As A Side Effect of Bromocriptine Treatment
NEJM 303:1418, Blum,I.,et al, 1980

Bromocriptine in Parkinson Disease:Further Studies
Neurol 29:363-369, Lieberman,A.N.,et al, 1979

Reduction in Size of a Pituitary Tumor by Bromocriptine Therapy
NEJM 300:291-293, McGregor,A.M.,et al, 1979

The Prolactinoma Problem
NEJM 300:313-315, Reichlin,S., 1979

Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979

Effect of Bromocriptine on Pituitary Tumor Size
BMJ 2:700-703, McGregor,A.M.,et al, 1979

Bromocriptine Fails To Stop Growth of Eosinophilic Adenoma In Acromegaly
NEJM 301:386, Salti,I.S., 1979

Drug Therapy, Bromocriptine
NEJM 301:873-878, Parkes,D., 1979

The Role of Bromocriptine in the Treatment of Parkinsonism
Neurol 29:1077-1083, Fahn,S.,et al, 1979

Lergotrile in the Treatment of Parkinsonism
Neurol 28:699, Klawans,H.L.,et al, 1978

Prolactin-Secreting Tumors & Hypogonadism in 22 Men
NEJM 299:847-852, Carter,J.N.,et al, 1978

Dopamine-Phenytoin Interaction, A Cause of Hypotension in the Critically Ill
Arch Surg 113:245-249, Bivins,B.A.,et al, 1978

Apomorphine Hydrochloride-Induced Improvement in Huntington's Chorea
Arch Neurol 35:27, Corsini,G.U.,et al, 1978

Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978

Comparison Between Lergotrile & Bromocriptine in Parkinsonism
Ann Neurol 3:319, Teychenne,P.F.,et al, 1978

Bromocriptine in Parkinsonism
Arch Neurol 35:503, Lees,A.J.,et al, 1978

The Medical Letter
Bromocriptine, 19:1011977., , 1977

Prolactin-secreting Pituitary Tumors
Ann Neurol 2:148, Antunes,J.L.,et al, 1977

Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977

Successful Use of Bromocriptine in the treatment of a Patient with Chronic Portasystemic Encephalopathy
NEJM 296:793, Morgan,M.Y.,et al, 1977

Galactorrhea:A Study of 235 Cases, Including 48 with Pituitary Tumors
NEJM 296:589, Kleinberg,D.L.,et al, 1977

Developments in the Treatment of Parkinsonism
NEJM 295:1433, Calne,D.B., 1976

Studies with Bromocriptine Part 2. Double-blind Comparison with Levodopa in Idiopathic Parkinsonism
Neurol 26:511, Kartzinel,R.,et al, 1976

Treatment of Parkinson's Disease with Bromocriptine
NEJM 295:1400, Lieberman,A.,et al, 1976

Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975

Huntington's Chorea-Deficiency of Y-Aminobutynic Acid in Brain
NEJM 288:337, 1973, 289:104, 1973, 292:10295., Perry,T.,et al, 1975

Facial Hyperkinesis
BMJ 626, Jun1974., , 1974

Drug Therapy of Parkinsonism
NEJM 287:20, Yahr,M.,et al, 1972

Implications of Amphetamine-Induced Stereotyped Behavior as a Model for Tardive Dyskinesias
Arch Gen Psychiat 27:502-507, Rubovits,R.,et al, 1972

Cholinergic & Dopaminergic Mechanisms in Huntington's Chorea
Life Sciences 10:405 1971., Aquilonius,S.,et al, 1971

Dopamine & Disease
C M A Journ 103:824, Barbeau,A., 1970

Neuropsychopharmcology & the Affective Disorders
NEJM 281:197, 1969 (three parts) ., Schildkraut,J.J., 1969

Showing articles 200 to 236 of 236 << Previous